Filing Details
- Accession Number:
- 0001181431-12-041525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-20 16:23:10
- Reporting Period:
- 2012-07-18
- Filing Date:
- 2012-07-20
- Accepted Time:
- 2012-07-20 15:23:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456615 | Arthur Greenberg | C/O Galectin Therapeutics Inc. 7 Wells Avenue, Suite 34 Newton MA 02459 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-18 | 5,000 | $1.84 | 94,667 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person in a Form 4 filed on April 18, 2012, voluntarily reported a purchase of the issuer's common stock on April 17, 2012, that was a small acquisition within the meaning of Rule 16a-6 under the Exchange Act that qualified for deferred reporting on Form 5. Had the reporting person elected deferred reporting under Rule 16a-6 for the April 17, 2012 purchase, such purchase when aggregated with the purschase reported herein would have triggered a Form 4 report pursuant to Rule 16a-6(a)(1), but insofar as it has been previously reported, the prior purchase, to avoid confusion, is not included in this report.
Billionaire Hedge Funds
